As of November 2024, Allogene Therapeutics has a market cap of $498.10M. This makes Allogene Therapeutics the world's 11449th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $815.30M | 50.93% |
2023 | $540.17M | -48.97% |
2022 | $1.06B | -57.84% |
2021 | $2.51B | -40.89% |
2020 | $4.25B | -2.85% |
2019 | $4.37B | -3.53% |
2018 | $4.53B | - |